Adenoid cystic carcinoma (ACC) is a rare, insidious malignancy, most commonly originating in the salivary glands, that presents unique diagnostic and therapeutic challenges. Recent decades have seen a ...
Adenoid cystic carcinoma (ACC) of the breast is a rare and distinctive form of breast cancer, accounting for less than 0.1% of all breast malignancies. Despite its triple‐negative immunophenotype, ...
Rgenta Therapeutics Inc. has received IND clearance by the FDA for RGT-61159, which is being developed for adenoid cystic carcinoma, colorectal cancer and other solid tumors, as well as acute myeloid ...
A new paper published by researchers at Fox Chase Cancer Center highlights the case of a patient who was diagnosed with adenoid cystic carcinoma (ACC) after a molecular panel identified the presence ...
Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC). This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This ...
Target volume delineation in locally advanced squamous cell carcinoma of the head and neck (SCCHN) using FDG-PET/CT images post-induction chemotherapy (IC). This is an ASCO Meeting Abstract from the ...
As our understanding of breast cancer grows, it’s clear treatment will not be the same for each person. Our mission is to research each rare cancer type so we can improve treatments. Out of every 100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results